Erratum: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice (PLoS Pathog (2020) 16:4 (e1008477) DOI: 10.1371/journal.ppat.1008477)

Nicole Caduff, Donal McHugh, Anita Murer, Patrick Rämer, Ana Raykova, Vanessa Landtwing, Lisa Rieble, Christian W. Keller, Michael Prummer, Laurent Hoffmann, Janice K.P. Lam, Alan K.S. Chiang, Friedrich Raulf, Tarik Azzi, Christoph Berger, Tina Rubic-Schneider, Elisabetta Traggiai, Jan D. Lünemann, Michael Kammüller, Christian Münz

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

The following information is missing from the Funding statement: AKSC was supported by a HMRF grant (18170462).

Original languageEnglish
JournalPLoS Pathogens
Volume16
Issue number12
DOIs
StatePublished - 21 Dec 2020
Externally publishedYes

Fingerprint

Dive into the research topics of 'Erratum: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice (PLoS Pathog (2020) 16:4 (e1008477) DOI: 10.1371/journal.ppat.1008477)'. Together they form a unique fingerprint.

Cite this